Huang Dennis Karl
- SEC CIK
- 0001641217
No open-market purchases or sales filed in the past year.
Current role at each company
- RARE Ultragenyx Pharmaceutical Inc.See Remarksas of Apr 20, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Huang Dennis Karl as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2023 (view filing) | Mar 1 | 2 days | Huang Dennis KarlSee Remarks | SSale | −389 | $45.65 | −$17.8K | −0.5%75.3K after | |
| Mar 3, 2022 (view filing) | Mar 1 | 2 days | Huang Dennis KarlSee Remarks | SSale | −3.23K | $66.62 | −$215.4K | −8.1%36.9K after | |
| Oct 18, 2021 (view filing) | Oct 14 | 4 days | Huang Dennis KarlEVP & Chief Tech Ops Officer | SSale | −358 | $81.14 | −$29.0K | −0.9%40.1K after |